MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by POLAND, A.
Right arrow Articles by GLOVER, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by POLAND, A.
Right arrow Articles by GLOVER, E.

Molecular Pharmacology, Vol 13, 924-938, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Chlorinated Biphenyl Induction of Aryl Hydrocarbon Hydroxylase Activity: a Study of the Structure-Activity Relationship

ALAN POLAND 1 and EDWARD GLOVER 1

1 Department of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Of 16 halogenated biphenyls examined for their capacity to induce hepatic aryl hydrocarbon hydroxylase activity in the chicken embryo, only three congeners, 3,4,3',4'-tetrachlorobiphenyl, 3,4,5,3',4',5'-hexachlorobiphenyl, and 3,4,5,3',4',5'-hexabromobiphenyl, were active. They were approximately equipotent in the chicken embryo, with ED50 values of approximately 90 nmoles/kg. These three chlorobiphenyl congeners also induced hepatic aryl hydrocarbon hydroxylase activity in C57BL/6J mice and rats, and they competitively bound the hepatic cytosol binding species thought to be the receptor for the induction of this enzyme. Among the halogenated biphenyls, there appear to be two structural requirements for induction of aryl hydrocarbon hydroxylase activity: the presence of at least 2 adjacent halogen atoms in the lateral positions of each benzene ring (positions 3,4,3',4' or 3,4,5,3',4',5') and the absence of halogen atoms adjacent to the biphenyl bridge (positions 2,6,2', and 6'); such substitutions lead to marked nonplanarity of the molecule. The halobiphenyl congeners that induced aryl hydrocarbon hydroxylase activity did not induce aminopyrine N-demethylase activity (a measure of phenobarbital-like activity); however, some of the congeners that failed to induce aryl hydrocarbon hydroxylase activity did induce aminopyrine N-demethylase. This suggests that while the commercial mixture of chlorobiphenyls, Aroclor 1254, induces a mixed pattern of microsomal monooxygenase activity resembling the combined administration of 3-methylcholanthrene and phenobarbital, any given chlorobiphenyl congener appears to produce only a 3-methylcholanthrene-like or a phenobarbital-like response (or the congener may be devoid of both activities). 3,4,3',4'-Tetrachlorobiphenyl, the prototype of the halobiphenyls that induce hepatic aryl hydrocarbon hydroxylase activity, is an approximate isostereomer of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,7,8-tetrachlorodibenzofuran, and 3,4,3',4'-tetrachloroazoxybenzene, all of which induce hepatic aryl hydrocarbon hydroxylase activity but which are over 100-fold more potent. Conversion of 3,4,3',4'-tetrachlorobiphenyl to a more rigid, planar analogue, 2,3,6,7-tetrachlorobiphenylene, produced a compound roughly equipotent to TCDD in inducing hepatic aryl hydrocarbon hydroxylase activity in the chicken embryo.

Submitted on February 24, 1977
Accepted on May 10, 1977




This article has been cited by other articles:


Home page
CarcinogenesisHome page
T. Shimada, K. Inoue, Y. Suzuki, T. Kawai, E. Azuma, T. Nakajima, M. Shindo, K. Kurose, A. Sugie, Y. Yamagishi, et al.
Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice
Carcinogenesis, July 1, 2002; 23(7): 1199 - 1207.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hossain, S. Tsuchiya, M. Minegishi, M. Osada, S. Ikawa, F.-a. Tezuka, M. Kaji, T. Konno, M. Watanabe, and H. Kikuchi
The Ah Receptor Is Not Involved in 2,3,7,8-Tetrachlorodibenzo- p-dioxin-mediated Apoptosis in Human Leukemic T Cell Lines
J. Biol. Chem., July 31, 1998; 273(31): 19853 - 19858.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
E. McConnell, G. Lucier, R. Rumbaugh, P. Albro, D. Harvan, Hass JR, and M. Harris
Dioxin in soil: bioavailability after ingestion by rats and guinea pigs
Science, March 9, 1984; 223(4640): 1077 - 1079.
[Abstract] [PDF]


Home page
ScienceHome page
G. Sweeny, K. Jones, F. Cole, D Basford, and F Krestynski
Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin
Science, April 20, 1979; 204(4390): 332 - 335.
[Abstract] [PDF]


Home page
ScienceHome page
H Shichi, D. Gaasterland, N. Jensen, and D. Nebert
Ah locus: genetic differences in susceptibility to cataracts induced by acetaminophen
Science, May 5, 1978; 200(4341): 539 - 541.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics